Your SlideShare is downloading. ×
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
ELIGIBILITY OF APPLICANT
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

ELIGIBILITY OF APPLICANT

373

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
373
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. International Competitive Grants Award Program for Young Investigators 2007 APPLICATION
  • 2. Letter from the Chairman and Introduction Dear Young Investigator: INTRODUCTION It is with great pleasure that I invite you to submit your application for The International Competitive Grants The International Competitive Grants Award Program Award Program for Young Investigators. This 2-year for Young Investigators is a 2-year international international grant program is made possible by an program enabling young investigators who have educational grant provided by the GlaxoSmithKline completed medical school within the past 10 years to Research & Education Foundation for Cardiovascular obtain funding for innovative research in Disease. The program enables Young Investigators to cardiovascular disease. obtain funding for innovative research in cardiovascular disease. Young Investigators are defined as individuals who have graduated medical school within the past 10 years The Foundation was established to promote the and are either currently enrolled in the later years of a development of a new generation of cardiovascular cardiology fellowship program (beyond 2 years), are clinician-scientists by supporting education on junior faculty members, or physicians who have critical topics in cardiovascular diseases, supporting completed a cardiology training program within the innovative research programs, and creating past 3 years. opportunities for international exchange of ideas. The grants award program is designed to foster the Eligible candidates are required to submit a 2-year development of independent research and to research plan on basic science or clinical research in encourage leadership in new scientists. cardiovascular disease according to criteria outlined herein. Research proposals must be reviewed and The Foundation Committee is comprised of signed by the applicant’s research advisor and must be dedicated international leaders who share the vision accompanied by a 1-page letter of recommendation, of developing quality research scientists in which outlines the career path and commitment of the cardiovascular disease. It is with this in mind that Young Investigator. we ask you to send your research proposal to the Committee for consideration. A total of 6 grants are awarded annually. Each grant is $55,000 per year for 2 years. The grant should be Please take the time to review the instructions and used for salary support, unless salary is already complete the application. On behalf of the covered, in which case the grant may be applied to International Review Committee, we look forward to other research costs. A stipulation for this grant is that reviewing your application. the recipient’s institution may not sequester more than 10% for indirect costs. Because research proposals Sincerely, must be sustainable for a minimum of 2 years, it is imperative that applicants maintain the ability to fulfill their research commitment in accordance with the requirements and expectations set forth by the Valentin Fuster, MD, PhD Foundation. To continue to receive the grant Chairman annually, progress reports will be required at 10 months and 22 months from the date of the grant issuance. If progress is not deemed sufficient, the grant may be discontinued. A complete report will be required at the conclusion of the grant period in September 2009. Grant recipients who publish their research during or following the completion of the grant are required to make proper acknowledgments to the GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease.
  • 3. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease: International Review Committee THE STRENGTH OF LEADERSHIP An International Review Committee comprised of world-renowned cardiologists and leading physician-scientists will review each application and collectively determine the 6 grant recipients. The chairman for the GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease and the International Review Committee is: Valentin Fuster, MD, PhD, Chairman Richard Gorlin, MD/Heart Research Foundation Professor of Cardiology Director, The Zena and Michael A. Wiener Cardiovascular Institute and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health Mt Sinai School of Medicine New York, NY Committee Members A. John Camm, MD, FRCP Professor of Clinical Cardiology The Prudential Chair of Cardiology St George’s Hospital Medical School University of London Honorary Consultant in Cardiology St George’s Hospital London, England Henry J. Dargie, MB, FRCP Consultant Cardiologist Cardiology Department Western Infirmary University of Glasgow Glasgow, Scotland Barry M. Massie, MD Professor of Medicine Chief, Cardiology Division San Francisco VA Medical Center University of California, San Francisco San Francisco, CA Christine E. Seidman, MD Director, Cardiovascular Genetics Center Department of Genetics Harvard Medical School Brigham and Women’s Hospital Boston, MA
  • 4. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease: International Review Committee Uppsala, Sweden James Shepherd, MB, ChB, PhD Michael A. Weber, MD Professor Professor of Medicine Head of the Department and Honorary Consultant State University of New York Downstate of Brooklyn, NY Vascular Biochemistry Royal Infirmary John Wilding, DM, FRCP Glasgow, Scotland Reader in Medicine Clinical Sciences Centre Lars Wallentin, MD, PhD University Hospital Aintree Professor of Cardiology, Department Head Liverpool, England Uppsala Clinical Research Center ELIGIBILITY OF APPLICANT RESEARCH AREAS Eligible candidates (Young Investigators) with Basic science and clinical research will be demonstrated experience in basic science or considered in all cardiovascular therapeutic clinical research must be licensed physicians areas, such as: (with or without a PhD) who have completed medical school within the past 10 years and • Atherosclerosis • Dyslipidemia 1. are currently enrolled in the later years of a • Thrombosis cardiology fellowship program (their first • Arrhythmia year of funding must be in at least their • Hypertension second year of fellowship) • Congestive heart failure 2. are junior faculty • Stroke • Diabetes 3. have completed their cardiology specialty training within the past 3 years Disciplines in cardiovascular research that will (international). be considered include, but are not restricted to: If the above criteria are not met, the application • Imaging will not be accepted for review. • Molecular biology • Genetics, genomics Individuals with R01 grants are not eligible. • Health economics Accepted candidates may transfer the grant to • Myocardial metabolism another institution or research group. • Integrated physiology Applicants may also continue from a third-year • Rheology of hemodynamics fellowship into a junior faculty position, • Stem-cell transplantation provided the same study will be continued and • Visionary research (ie, novel receives written consent from the committee. • risk factors, database analysis, and genetic epidemiology)
  • 5. Instructions for Submission 1. FORMAT salaries are requested. Provide a 1-2 paragraph biosketch of each key person. • Follow the outlined format stated below • Arial or Helvetica font is preferred. Font sizes smaller than 10 point are not Budget (1 page) acceptable The grant is intended to be used for salary. If • All categories must be filled out completely salary is already accounted for, the grant may be for the application to be considered applied to other direct research costs. In this • If a specific section of the application does section, provide a summary of how your grant is not apply to you, please indicate “not to be used. A stipulation for this grant is that applicable.” the recipient’s institution may not sequester more than 10% for indirect costs. If the grant is 2. APPLICATION only being used for salary, it is acceptable to state this information only. Applicant Information Form, This form must be filled out completely and Research Plan: Specific Aims (1 page) include all pertinent signatures. List the broad, long-term objectives and goals of the specific research proposed. Research Advisor Information This form must be filled out completely and Research Plan: Background and Significance (3 pages) include the research advisor’s signature. Briefly review the background that lead to the An abbreviated curriculum vitae (CV) of the present application, critically evaluating existing research advisor is required. We will not accept knowledge and specifically identifying gaps that an addendum with a complete CV. Please this project is intended to fill. Identify the health utilize the designated form provided to relevance by relating to the specific aims and complete this information, or provide the longer term objectives. If the goals of the information in similar format in your submitted research are achieved, provide information on documents. Provide a list of publications that how scientific knowledge or clinical practice will demonstrates the advisor’s research and be advanced. expertise in the field being studied by the applicant. Research Plan: Preliminary Studies (3 pages) Review your preliminary work that is applicable Abstract (1 page) The abstract summarizes the project, and is a to this application. Through this work, succinct and accurate description of the demonstrate your experience and competence proposed work when separated from the needed to pursue this project to its completion. application. State the applications broad, long- Research Plan: Research Design and Methods term objectives and specific aims, addressing (8 pages) relation to health. Describe the research design Describe the research-design conceptual or and methods for achieving research goals. In a clinical framework, procedures, and analyses to few sentences, describe the relevance to public be used to accomplish the specific aims of the health. project. Include how data is to be collected, analyzed, and interpreted. Describe any new Key Personnel (1 page) methodologies over existing concepts, List the names, title, organization, and role on approaches, tools, or technologies for the project of key personnel that will be involved in proposed project. Describe any difficulties or this project. Start with yourself as the principal limitations of the proposed procedures and investigator, then your research advisor, and alternative approaches to achieve these aims. other key personnel instrumental to its Also, provide a sequence and timetable for the completion. These personnel must devote project. measurable effort to the project, whether or not
  • 6. Literature Cited (3 pages) E-mail All references listed must conform to AMA E-mail the complete application as a Microsoft style. Each reference must include the title, Word 6.0 or later or as an Adobe Acrobat 6.0 or names of all authors, book or journal volume later format to grants@stimedinfo.com. numbers, and year of publication. The Applications may include documents in various references should be limited to relevant and formats (ie, forms in Adobe Acrobat and all other current literature. information in Microsoft Word). All documents and the subject line of the e-mail must be labeled Description of Facility/Resources for “Your name, Dept 2383.” All required Conducting Research (1 page) application information must be included in your Describe the facility, laboratory, and resources submission. If you are unable to e-mail your that are available to you to conduct this letter of recommendation, please note this in the research. If special equipment is required, e-mail and identify which method the letter will please describe the experience with this be coming under separate cover (ie, fax or mail). equipment to demonstrate competence. Scanned signatures are permitted for forms and letters. Listing of Active Grants (2 pages) Provide a list of all grants under which you are Mail currently working, and the nature of the project Mail 1 printout of the completed application to: they are funding. International Competitive Grants Award Program for Young Investigators 3. RESEARCH ADVISOR LETTER OF Scientific Therapeutics Information, Inc, Dept 2383 RECOMMENDATION 505 Morris Ave, 3rd Floor, Springfield, NJ 07081 The review committee must receive a letter of Fax recommendation from the candidate’s research Fax 1 printout of the completed application to advisor, which addresses the research potential 973-376-0611, attention International for the candidate and the career-development Competitive Grants Award Program for Young plan. The letter should indicate that the research Investigators, Dept 2383. advisor has reviewed and approved the application. Please note the research advisor 6. DEADLINE should also sign the application on the second page of the form. Submission deadline is 5:00 PM (US EST) on December 1, 2006. 4. ADDENDUM 7. NOTIFICATION AND ANNOUNCEMENT OF The review committee requires all applicants to WINNERS provide their complete CV as an addendum. Figures relevant to the research should also be Winners of the International Competitive Grants included. Award Program for Young Investigators will be notified in late January 2007. 5. SUBMISSION An electronic version of the application can be downloaded from www.cvfoundation.org in either Adobe Acrobat (PDF) or Microsoft Word format. The following are 3 acceptable ways to submit the completed application. Please utilize only 1 method, unless otherwise requested:
  • 7. 8. AWARDS/RESPONSIBILITY OF AWARDEES APPLICATION APPLICATION CHECK COMPONENTS All grants will be funded beginning on OFF LIST July 1, 2007, and annually thereafter. Progress Please see below for a reports are due on April 1, 2008 and list of all components Before you submit April 1, 2009. A full research report will be due that should be in September 2009 following the conclusion of your application, please make certain included in your the grant period. Details outlining these application: responsibilities will be forwarded to the grant that the following information is winners after selection. The grant recipient • Applicant winners will be honored at a dinner reception included: Information Form during the 56th Annual Scientific Session of the • Abstract (1 page) American College of Cardiology Scientific • All sections of the application have • Key Personnel (1 Session in New Orleans on March 24–27, 2007. page) Further information will be forthcoming. been completed, or if something • Budget (1 page) does not apply, • Research Plan: 9. ADDITIONAL APPLICATIONS/QUESTIONS Specific Aims (1 An electronic version of the application can be “not applicable” (N/A) has been page) downloaded from www.cvfoundation.org. If indicated • Research Plan: you have any questions or need additional • All signatures are Background and printed copies of the application, please call complete: you Significance 973-376-5655 x204 between the hours of 9:00 AM have signed and (3 pages) and 5:00 PM EST, or e-mail dated your • Research Plan: grants@stimedinfo.com. application, your Preliminary research advisor Studies (3 pages) has signed and • Research Plan: dated your Research Design application, and and Methods the individual (8 pages) and institutional • Literature Cited (3 authorization has pages) been signed and • Description of dated. Facility/Resource s for Conducting Research (1 page) • Listing of Active Grants (2 pages) • Research Advisor Letter of Recommendation • Addendum : Curriculum Vitae and Relevant Figures Please note pages listed are maximum allowable pages.
  • 8. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” GRANT APPLICATION TITLE OF PROJECT: PRINCIPAL INVESTIGATOR INFORMATION Name/Degree(s): New Investigator: No Yes Applicant’s Current Position Title: Department, Service, Laboratory or Equivalent: Current Status of Training: US Applicant Status: Fellow (2nd year or later) Junior Faculty Other: International Applicant Status: Fellowship/cardiology training completed within past 3 years Junior Faculty Other: Applicant Organization Name (Institution): Applicant Organization Address: Administrative Official to be Notified if Award is Made: Street Address (For correspondence - no PO boxes): Name: Title: Address: City: State/Province/Country: Postal Code: Phone: Phone: Fax: Fax: Email: Email: Applicant organization certification and acceptance: I certify that the statements herein are true, complete and accurate to the best of my knowledge, and accept the obligation to comply with the terms and conditions if a grant is awarded as a result of this application. I criminal, civil or administrative penalties. Signature of Applicant Date Signature of Official named above Date Please indicate how you were informed of this program: Research Advisor/Colleague Foundation web site Journal Ad Annual meetings: AHA/ESC/ACC Medical School mailing Other (please specify)
  • 9. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” If you wish to obtain an electronic version of this form, go to www.cvfoundation.org.
  • 10. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” RESEARCH ADVISOR INFORMATION Name/Degree(s) Title/Institution Street Address (for correspondence - no PO boxes) City State/Province/Country: Postal Code MD Received From Year PhD Received From Year RESEARCH ADVISOR ABBREVIATED CURRICULUM VITAE Present Position Prior Position Mentorship (Scientific) Courses Organized Grants Received Other Research Advisor Assurance: I certify that the statements herein are true, complete and accurate to the best of my knowledge, and accept the obligation to comply with the terms and conditions if a grant is awarded as a result of this application. I am aware that any false, fictitious or fraudulent statements or claims may subject me to criminal, civil or administrative penalties. I agree to accept responsibility for the scientific conduct of the project and to provide the required progress reports if a grant is awarded as a result of this application. ________________________________________________________________________________________________________________________________________________ Signature of Official named above Date
  • 11. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” ABSTRACT (1-page)
  • 12. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” KEY PERSONNEL (1 page) Name Organization Role on Project
  • 13. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” BUDGET (1 page) Please describe the allocation of your annual budget. If used for salary, what portion and for whom. If salary is covered, how will funding be used?
  • 14. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” RESEARCH PLAN: SPECIFIC AIMS (1 page)
  • 15. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” RESEARCH PLAN: BACKGROUND AND SIGNIFICANCE (3 pages)
  • 16. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” RESEARCH PLAN: PRELIMINARY STUDIES (3 pages)
  • 17. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” RESEARCH PLAN: RESEARCH DESIGN AND METHODS (8 pages)
  • 18. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” LITERATURE CITED (3 pages)
  • 19. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” DESCRIPTION OF FACILITY/RESOURCES FOR CONDUCTING RESEARCH (1 page)
  • 20. GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease “2007 International Competitive Grants Award Program for Young Investigators” LISTING OF ACTIVE GRANTS (2 pages)

×